Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

TSXV:VIV - Post Discussion

Avivagen Inc > updated presentation
View:
Comment by DrJayser on Sep 02, 2020 3:45pm
The level of professionalism knows no bound! The last slide states May 2020.   No talk of cat food! I cannot believe it! What happened? clients were screaming for it. BACK IN 2013.........................   18.1T Sold in the Philippines not last quarter, IN THE LAST 4 YEARS!!!!!!!!   TALK ABOUT A DISRUPTIVE PRODUCT, SIMPLY AMAZING. 412,000$ FOR THE CEO . STONEHEAD IS A RETARD
Comment by DrJayser on Sep 02, 2020 3:50pm
LAST QUARTER THE CEO MADE 100,000$ IN SALARY ,WHILE THE AVIVAGEN HAS SALES OF 30,000$ AND A GROSS MARGIN OF 15,000$....... sales in 2020 are running 50% below 2019...... Buy, Buy, Buy  its truly dispruptive!
Avivagen Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities